HSIC Company Profile and Key Details
NASDAQ : HSIC
Henry Schein
$87.52
-1.41-1.59%
At Close 4:00 PM58.03
B-ESG ScoreESG Rating
Price Chart
Stock Price Today
Henry Schein, Inc. (HSIC) stock declined over -1.59%, trading at $87.52 on NASDAQ, down from the previous close of $88.93. The stock opened at $89.13, fluctuating between $87.26 and $89.13 in the recent session.
Stock Snapshot
88.93
Prev. Close
9.97B
Market Cap
87.26
Day Low
16.48
P/E Ratio
5.31
EPS (TTM)
2.41
Cash Flow per Share
89.13
Open
113.92M
Number of Shares
89.13
Day High
98.55%
Free Float in %
28.16
Book Value
1.44M
Volume
Relevant Articles
SEC Fillings
Current Report (8-k)
| Filing Date | Accepted Date | |
|---|---|---|
Annual Report (10-k)
| Filing Date | Accepted Date | |
|---|---|---|
Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | 88.93 | 88.93 | 87.26 | 87.52 | 1.44M |
| Sep 14, 2026 | 88.57 | 89.12 | 87.65 | 88.93 | 818.35K |
| Sep 11, 2026 | 88.54 | 88.79 | 87.36 | 88.36 | 713.84K |
| Sep 10, 2026 | 88.20 | 88.22 | 87.11 | 87.30 | 1.15M |
| Sep 09, 2026 | 88.14 | 88.92 | 87.65 | 87.97 | 754.31K |
| Sep 08, 2026 | 89.50 | 89.99 | 88.71 | 88.86 | 671.8K |
| Sep 04, 2026 | 89.91 | 90.54 | 89.65 | 89.81 | 774K |
| Sep 03, 2026 | 90.68 | 91.69 | 89.56 | 90.86 | 679.33K |
| Sep 02, 2026 | 89.02 | 91.36 | 88.61 | 90.39 | 859.38K |
| Sep 01, 2026 | 89.80 | 90.15 | 88.00 | 88.52 | 717.9K |
| Aug 31, 2026 | 88.93 | 90.00 | 88.16 | 89.80 | 1.09M |
| Aug 28, 2026 | 90.54 | 91.09 | 89.47 | 89.52 | 795.95K |
| Aug 27, 2026 | 90.30 | 91.39 | 89.61 | 90.28 | 784.42K |
| Aug 26, 2026 | 89.97 | 90.67 | 89.49 | 90.38 | 696.8K |
| Aug 25, 2026 | 89.19 | 89.84 | 88.74 | 89.65 | 819.5K |
| Aug 24, 2026 | 88.50 | 89.71 | 87.67 | 89.51 | 668.48K |
| Aug 21, 2026 | 88.74 | 89.11 | 88.19 | 88.50 | 758.14K |
| Aug 20, 2026 | 89.00 | 89.69 | 88.41 | 88.46 | 851.46K |
| Aug 19, 2026 | 90.11 | 91.29 | 89.17 | 89.29 | 1.18M |
| Aug 18, 2026 | 89.94 | 90.46 | 88.73 | 89.23 | 1.03M |
Contact Details
About Company
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.
Company Information
| Employees | 25000 |
| Beta | 0.81 |
| Sales or Revenue | $12.34B |
| 5Y Sales Change% | 0.092% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Distribution |
Stock Peers
PDCO
-0.28-0.90%
Patterson Companies, Inc.$31.33EMPG00
Empro Group Inc. Ordinary shares$17.36WGRX00
Wellgistics Health, Inc.$3.52YI-0.01-0.29%
111, Inc.$3.49MEDS0.7547+87.22%
DataMEDS AI, Inc.$1.62RDGT-0.022-2.63%
Ridgetech, Inc.$0.82AHG-0.0418-5.21%
Akso Health Group$0.76ZYXI0.073+140.38%
Zynex, Inc.$0.13HKPD-0.0116-9.29%
Cellyan Biotechnology Co., Ltd$0.11SNYR-0.0087-9.56%
Synergy CHC Corp.$0.08Company Overview
Henry Schein, Inc. (NASDAQ:HSIC) closed at $87.52 USD, losing -$1.41 (-1.59%) from the previous close of $88.93. The stock is currently mid-range between its 52-week high and low $61.95 and $92.18. With a market capitalization of about $9.97 billion, Henry Schein, Inc. is classified as a mid-cap and shows market-like volatility (beta ~0.81). Key stats such as the average daily volume over the past year has been around 1.21 million shares, in line with its 52-week average. Headquartered in Melville, NY, Henry Schein, Inc. operates in the Healthcare sector and the Medical - Distribution industry. Led by CEO Frederick Lowery, the company employs approximately 25,000 people and listed since November 03, 1995. Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services.
Technical Performance
Short-term trend indicators are bearishly aligned (SMA20 3.88%, SMA50 4.83%, SMA200 13.71%). The stock’s 14-day RSI is 58.13 (neutral), while the ATR of 2.72 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -8.76% below its high and over 34.53% above its low. Average 10-day trading volume of 924.67 thousand shares is below the 3-month average of 1.16 million, indicating normal recent market interest.
Valuation Metrics
Henry Schein, Inc. trades at a P/E ratio of 25.28, slightly below the S&P 500 average, with a price-to-sales ratio of 0.73 and a price-to-book ratio of 3.14 trading at moderately above to book value. The P/FCF stands at 18.49, also above market averages.
Dividend & Fair Value
Henry Schein, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $57.03. This means the shares are trading above this model’s fair value.
Shareholding & Insider Activity
Henry Schein, Inc. has 111.45 million shares outstanding. The public float is 91.42 million shares, elevated short interest at 6.85% of float. This equals 6.30 million shares. The short ratio is 4.71 days. Institutional investors hold 108.98% of the float. Insiders own 0.82%. BERGMAN STANLEY M holds 383.80 thousand shares, BRESLAWSKI JAMES P has 209.56 thousand shares and PALADINO STEVEN has 144.62 thousand shares. Over the past six months, insider transactions show balanced activity. They sold 1.36 thousand shares across 1 transactions.
Financial & Profitability Overview
On valuation metrics, Henry Schein trades at a P/E of 25.28, P/S of 0.73 and P/B of 3.14. The current ratio is 1.32 and quick ratio is 0.73. Operationally, the company’s inventory turnover is 4.60 and cash conversion cycle is 82.89 days. Debt-to-equity is 1.21, supported by a cash flow-to-debt ratio of 0.18.
Quarterly Financial Highlights
The company ended the quarter with $171.00M in cash and short-term investments, a total debt of $2.74B, and net debt of $2.57B. Total assets were $10.57B, with equity of $5.15B. Financials further reflected stability, with operating cash flow of $500.00M, free cash flow of $313.00M, and capital expenditures of - $187.00M.
Price Forecast & Outlook
Our AI price prediction model suggests that Henry Schein, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -2.94%, with price expected at $84.95 by September 29, 2026, within a range of $83.63 to $86.20 3-Month Outlook: Projected fall of -2.27%, reaching $85.53 by December 11, 2026, with a range of $78.51 to $91.21. 1-Year Outlook: Projected gain of 4.65%, with price at $91.59 by September 15, 2027, within a range of $89.75 to $93.72.
Key Takeaways
Henry Schein, Inc. (NASDAQ:HSIC) shares are flat 2.84% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Henry Schein, Inc. trading at a premium to the broader market with a P/E of 25.28. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $83.31, suggesting -4.81% downside. Our AI forecast model points to short-term weakness (-2.94% over two weeks), a medium-term fall (-2.27% over three months), and a longer-term gain (4.65% over one year), with expected trading ranges indicating moderate volatility.
Frequently Asked Questions
What is the current Henry Schein, Inc. (HSIC) stock price?
Henry Schein, Inc. (NASDAQ: HSIC) stock price is $87.52 in the last trading session. During the trading session, HSIC stock reached the peak price of $89.13 while $87.26 was the lowest point it dropped to. The percentage change in HSIC stock occurred in the recent session was -1.59% while the dollar amount for the price change in HSIC stock was - $1.41.
HSIC's industry and sector of operation?
The NASDAQ listed HSIC is part of Medical - Distribution industry that operates in the broader Healthcare sector. Henry Schein, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of HSIC?
Mr. Stanley M. Bergman
Executive Chairman & Chief Executive Officer
Mr. James P. Breslawski
Executive Vice Chairman & Pres
Mr. Steven Paladino
Executive Director
Mr. Michael Saul Ettinger
Executive Vice President & Chief Operating Officer
Mr. Ronald N. South
Senior Vice President & Chief Financial Officer
Mr. Christopher Pendergast
Senior Vice President & Chief Technology Officer
Graham Stanley
Vice President of Investor Relations & Strategic Fin. Project Officer
Ms. Olga Timoshkina
Vice President of Corporation Fin., Chief Accounting Officer & Corp. Controller
Mr. Walter Siegel
Senior Vice President & Chief Legal Officer
Mr. Bradford C. Connett
Chief Executive Officer of North America Distribution Group
Mr. Mark E. Mlotek
Executive Vice President, Chief Strategic Officer & Exec. Director
Executive Chairman & Chief Executive Officer
Mr. James P. Breslawski
Executive Vice Chairman & Pres
Mr. Steven Paladino
Executive Director
Mr. Michael Saul Ettinger
Executive Vice President & Chief Operating Officer
Mr. Ronald N. South
Senior Vice President & Chief Financial Officer
Mr. Christopher Pendergast
Senior Vice President & Chief Technology Officer
Graham Stanley
Vice President of Investor Relations & Strategic Fin. Project Officer
Ms. Olga Timoshkina
Vice President of Corporation Fin., Chief Accounting Officer & Corp. Controller
Mr. Walter Siegel
Senior Vice President & Chief Legal Officer
Mr. Bradford C. Connett
Chief Executive Officer of North America Distribution Group
Mr. Mark E. Mlotek
Executive Vice President, Chief Strategic Officer & Exec. Director
How HSIC did perform over past 52-week?
HSIC's closing price is 41.27% higher than its 52-week low of $61.95 where as its distance from 52-week high of $92.18 is -5.05%.
How many employees does HSIC have?
Number of HSIC employees currently stands at 25,000.
Link for HSIC official website?
Official Website of HSIC is: https://www.henryschein.com
How do I contact HSIC?
HSIC could be contacted at phone 631 843 5500 and can also be accessed through its website. HSIC operates from 135 Duryea Road, Melville, NY 11747, United States.
How many shares of HSIC are traded daily?
HSIC stock volume for the day was 1.44M shares. The average number of HSIC shares traded daily for last 3 months was 1.21M.
What is the market cap of HSIC currently?
The market value of HSIC currently stands at $9.97B with its latest stock price at $87.52 and 113.92M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep